Literature DB >> 7917576

Bone mineral densitometry in dialyzed patients: quantitative computed tomography versus dual photon absorptiometry.

P Lechleitner1, E Krimbacher, N Genser, L Fridrich, D zur Nedden, G Helweg, P Koenig, M Joannidis.   

Abstract

Reduced bone mineral density (BMD) increases risk of fractures, thus making it necessary to monitor patients suffering from chronic renal failure and consecutive disturbance of bone metabolism. In order to evaluate the reliability of available methods, bone mineral density of the lumbar spine assessed with single energy computed tomography (QCT) was compared with bone mineral density of the lumbar spine, femoral neck, Ward's triangle and trochanteric region measured by dual energy photon absorptiometry (DPA) in 45 hemodialyzed patients with a mean hemodialysis duration of 35 +/- 26 months (SD). Depending on the measurement site and method 4-34% of dialyzed patients suffered from reduced BMD (z-score < -2). The highest correlation (r = 0.61, p < 0.01) was found between QCT of the spine, trabecular bone, and DPA of Ward's triangle. One year after baseline measurement bone mineral density was reassessed after randomization to either QCT or DPA in 14 and 18 patients, respectively. Whereas lumbar spine and femoral neck did not change, mean BMD showed a decrease at the measurement sites of Ward's triangle (DPA), trochanteric region (DPA) and trabecular bone of the spine (QCT), which, however, was statistically not significant. Cortical BMD of the spine assessed with QCT showed an increase. Although there is some reduction in bone density at most sites in hemodialyzed patients, no significant bone loss could be demonstrated over the course of 1 year.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917576     DOI: 10.1016/8756-3282(94)90814-1

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  9 in total

1.  Bone mineral density and parathyroid function in patients on maintenance hemodialysis.

Authors:  Cs Ambrus; Cs Almasi; K Berta; Gy Deak; A Marton; M Zs Molnar; Zs Nemeth; Cs Horvath; P Lakatos; M Szathmari; I Mucsi
Journal:  Int Urol Nephrol       Date:  2010-01-21       Impact factor: 2.370

2.  Changes in bone mineral density at various sites in patients on hemodialysis due to chronic glomerulonephritis.

Authors:  T Miki; A Morita; K Nakatsuka; T Tabata; T Inoue; Y Nishizawa; H Morii
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  Bone mineral density and bone turnover markers in children with chronic renal failure.

Authors:  Ashraf M Bakr
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

Review 4.  Treatment of osteoporosis in chronic kidney disease and end-stage renal disease.

Authors:  Paul D Miller
Journal:  Curr Osteoporos Rep       Date:  2005-03       Impact factor: 5.096

5.  Determinants of prevalent vertebral fractures and progressive bone loss in long-term hemodialysis patients.

Authors:  Jan Mares; Kristina Ohlidalova; Sylvie Opatrna; Jiri Ferda
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

Review 6.  Osteoporosis after solid organ and bone marrow transplantation.

Authors:  Adi Cohen; Elizabeth Shane
Journal:  Osteoporos Int       Date:  2003-08-08       Impact factor: 4.507

Review 7.  Osteoporosis in the elderly with chronic kidney disease.

Authors:  F Fevzi Ersoy
Journal:  Int Urol Nephrol       Date:  2006-11-11       Impact factor: 2.266

8.  Single-centre cross-sectional study on the impact of cumulative erythropoietin on bone mineral density in maintenance dialysis patients.

Authors:  Chung-Yi Cheng; Yi-Jie Kuo
Journal:  BMJ Open       Date:  2022-04-12       Impact factor: 2.692

Review 9.  Vitamin D and UV exposure in chronic kidney disease.

Authors:  Rolfdieter Krause
Journal:  Dermatoendocrinol       Date:  2013-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.